Table 1.
Characteristic | N | % |
---|---|---|
Age at Diagnosis | ||
N | 213 | |
Mean | 61.3 ±10.6 | |
Median (Min-Max) | 61.0 (23.0–86.0) | |
BMI | ||
Mean | 35.2 ± 10.6 | |
Median (Min-Max) | 33.8 (15.5–74.4) | |
BMI | ||
Underweight (< 18.0) | 2 | 0.9 |
Normal (18.0 – 24.9) | 31 | 14.6 |
Overweight (25.0–29.9) | 48 | 22.5 |
Obese (≥30.0) | 132 | 62.0 |
FIGO Stage | ||
I | 151 | 70.9 |
II | 13 | 6.1 |
III | 29 | 13.6 |
IV1 | 20 | 9.4 |
Histology | ||
Endometrioid | 158 | 74.2 |
Serous | 15 | 7.0 |
Clear cell | 4 | 1.9 |
Mixed | 31 | 14.6 |
Carcinosarcoma | 3 | 1.4 |
Other | 2 | 0.9 |
Grade | ||
1 | 19 | 8.9 |
2 | 139 | 65.3 |
3 | 55 | 25.8 |
Depth of Myometrial Invasion | ||
0 | 41 | 19.3 |
<50 | 112 | 52.6 |
>50 | 60 | 28.2 |
Tumor Location2 | ||
C | 205 | 97.2 |
LUS | 3 | 1.4 |
C & LUS | 3 | 1.4 |
One patient was documented in the electronic medical record as “advanced” and therefore recorded as Stage IV disease for statistical purposes
For two patients, the exact site of tumor within the uterus is not known. C, uterine corpus; LUS, lower uterine segment